Formononetin inhibits the Smad3-ATF3-SLC7A11 pathway, increases SLC7A11 and GPX4 expression, promotes NRF2 nuclear accumulation, and ameliorates renal fibrosis and ferroptosis [208]. Here, SMAD3 is linked to renal fibrosis.